{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:45:29Z","timestamp":1787010329120,"version":"build-2736575974"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of the Report<\/jats:title>\n                    <jats:p>\n                      Although early detection of individuals at risk of dementia conversion is important in patients with Parkinson\u2019s disease (PD), there is still no consensus on neuroimaging biomarkers for predicting future cognitive decline. We aimed to investigate whether cerebral perfusion patterns on early-phase\n                      <jats:sup>18<\/jats:sup>\n                      F-N-(3-fluoropropyl)-2\u03b2-carboxymethoxy-3\u03b2-(4-iodophenyl) nortropane (\n                      <jats:sup>18<\/jats:sup>\n                      F-FP-CIT) PET have the potential to serve as a neuroimaging predictor for early dementia conversion in patients with PD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>\n                      In this retrospective analysis, we enrolled 187 patients with newly diagnosed PD who underwent dual-phase\n                      <jats:sup>18<\/jats:sup>\n                      F-FP-CIT PET at initial assessment and serial cognitive assessments during the follow-up period (&gt;5 years). Patients with PD were classified into 2 groups: the PD with dementia (PDD)-high-risk (PDD-H; n = 47) and the PDD-low-risk (PDD-L; n = 140) groups according to dementia conversion within 5 years of PD diagnosis. We explored between-group differences in the regional uptake in the early-phase\n                      <jats:sup>18<\/jats:sup>\n                      F-FP-CIT PET images. We additionally performed a linear discriminant analysis to develop a prediction model for early PDD conversion.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The PDD-H group exhibited hypoperfusion in Alzheimer\u2019s disease (AD)-prone regions (inferomedial temporal and posterior cingulate cortices, and insula) compared with the PDD-L group. A prediction model using regional uptake in the right entorhinal cortex, left amygdala, and left isthmus cingulate cortex could optimally distinguish the PDD-H group from the PDD-L group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Regional hypoperfusion in the AD-prone regions on early-phase\n                      <jats:sup>18<\/jats:sup>\n                      F-FP-CIT PET can be a useful biomarker for predicting early dementia conversion in patients with PD.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rlu.0000000000005211","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T01:00:10Z","timestamp":1712538010000},"page":"521-528","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Hypoperfusion in Alzheimer\u2019s Disease\u2013Prone Regions and Dementia Conversion in Parkinson\u2019s Disease"],"prefix":"10.1097","volume":"49","author":[{"given":"Min Young","family":"Chun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taein","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Hong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Sun","family":"Lee","sequence":"additional","affiliation":[{"name":"Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil Hyu","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young H.","family":"Sohn","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Jong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","year":"2006","journal-title":"Lancet Neurol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/brain\/awm111","article-title":"Evolution of cognitive dysfunction in an incident Parkinson's disease cohort","volume":"130","year":"2007","journal-title":"Brain"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neurobiolaging.2019.02.023","article-title":"Mild cognitive impairment reverters have a favorable cognitive prognosis and cortical integrity in Parkinson's disease","volume":"78","year":"2019","journal-title":"Neurobiol Aging"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s00259-012-2198-5","article-title":"Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease","volume":"39","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(16)30328-3","article-title":"Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study","volume":"16","year":"2017","journal-title":"Lancet Neurol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/hbm.24631","article-title":"Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment","volume":"40","year":"2019","journal-title":"Hum Brain Mapp"},{"key":"bib7-20250621","first-page":"e1846","article-title":"Association between white matter connectivity and early dementia in patients with Parkinson disease","volume":"98","year":"2022","journal-title":"Neurology"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/mds.27204","article-title":"APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease","volume":"33","year":"2018","journal-title":"Mov Disord"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1093\/brain\/awv211","article-title":"Baseline and longitudinal grey matter changes in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study","volume":"138","year":"2015","journal-title":"Brain"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/mds.28228","article-title":"Tracking cortical changes throughout cognitive decline in Parkinson's disease","volume":"35","year":"2020","journal-title":"Mov Disord"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jns.2016.11.068","article-title":"Longitudinal study of cognitive and cerebral metabolic changes in Parkinson's disease","volume":"372","year":"2017","journal-title":"J Neurol Sci"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.2967\/jnumed.120.257345","article-title":"Dynamic (18)F-FPCIT PET: quantification of Parkinson's disease metabolic networks and nigrostriatal dopaminergic dysfunction in a single imaging session","volume":"62","year":"2021","journal-title":"J Nucl Med"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/mds.29565","article-title":"Differential implications of cerebral hypoperfusion and hyperperfusion in Parkinson's disease","volume":"38","year":"2023","journal-title":"Mov Disord"},{"key":"bib14-20250621","first-page":"e1650","article-title":"Factor analysis\u2013derived cognitive profile predicting early dementia conversion in PD","volume":"95","year":"2020","journal-title":"Neurology"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","year":"2015","journal-title":"Mov Disord"},{"key":"bib16-20250621","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/mds.25383","article-title":"How to identify tremor dominant and postural instability\/gait difficulty groups with the Movement Disorder Society Unified Parkinson's Disease Rating Scale: comparison with the unified Parkinson's disease rating scale","volume":"28","year":"2013","journal-title":"Mov Disord"},{"key":"bib17-20250621","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12779\/dnd.2023.22.1.1","article-title":"The Seoul Neuropsychological Screening Battery (SNSB) for comprehensive neuropsychological assessment","volume":"22","year":"2023","journal-title":"Dement Neurocogn Disord"},{"key":"bib18-20250621","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.sleep.2011.01.015","article-title":"Utility of the REM Sleep Behavior Disorder Screening Questionnaire (RBDSQ) in Parkinson's disease patients","volume":"12","year":"2011","journal-title":"Sleep Med"},{"key":"bib19-20250621","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0022-510X(93)90041-V","article-title":"A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging","volume":"114","year":"1993","journal-title":"J Neurol Sci"},{"key":"bib20-20250621","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson's disease","volume":"22","year":"2007","journal-title":"Mov Disord"},{"key":"bib21-20250621","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/mds.21844","article-title":"Diagnostic procedures for Parkinson's disease dementia: recommendations from the Movement Disorder Society Task Force","volume":"22","year":"2007","journal-title":"Mov Disord"},{"key":"bib22-20250621","doi-asserted-by":"crossref","first-page":"14992","DOI":"10.1038\/s41598-021-94040-8","article-title":"Diagnostic accuracy of dual-phase (18)F-FP-CIT PET imaging for detection and differential diagnosis of parkinsonism","volume":"11","year":"2021","journal-title":"Sci Rep"},{"key":"bib23-20250621","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/mds.20216","article-title":"Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom","volume":"19","year":"2004","journal-title":"Mov Disord"},{"key":"bib24-20250621","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mds.28864","article-title":"Longitudinal white matter damage evolution in Parkinson's disease","volume":"37","year":"2022","journal-title":"Mov Disord"},{"key":"bib25-20250621","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/jnnp-2018-319592","article-title":"Hippocampal subfield atrophy of CA1 and subicular structures predict progression to dementia in idiopathic Parkinson's disease","volume":"90","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"bib26-20250621","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1212\/01.wnl.0000256697.20968.d7","article-title":"Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease","volume":"68","year":"2007","journal-title":"Neurology"},{"key":"bib27-20250621","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.nicl.2018.06.020","article-title":"Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: associations with clinical severity, glucose metabolism and tau PET","volume":"19","year":"2018","journal-title":"Neuroimage Clin"},{"key":"bib28-20250621","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","article-title":"Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease","volume":"42","year":"1997","journal-title":"Ann Neurol"},{"key":"bib29-20250621","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/mds.27867","article-title":"Pathological influences on clinical heterogeneity in Lewy body diseases","volume":"35","year":"2020","journal-title":"Mov Disord"},{"key":"bib30-20250621","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000354670","article-title":"The significance of \u03b1-synuclein, amyloid-\u03b2 and tau pathologies in Parkinson's disease progression and related dementia","volume":"13","year":"2014","journal-title":"Neurodegener Dis"},{"key":"bib31-20250621","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/jnr.23777","article-title":"Cerebral hypoperfusion and glucose hypometabolism: key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease","volume":"95","year":"2017","journal-title":"J Neurosci Res"},{"key":"bib32-20250621","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.902120102","article-title":"Insula of the old world monkey. I. Architectonics in the insulo-orbito-temporal component of the paralimbic brain","volume":"212","year":"1982","journal-title":"J Comp Neurol"},{"key":"bib33-20250621","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neuroimage.2014.05.052","article-title":"The salience network is responsible for switching between the default mode network and the central executive network: replication from DCM","volume":"99","year":"2014","journal-title":"Neuroimage"},{"key":"bib34-20250621","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/brain\/awt337","article-title":"Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment","volume":"137","year":"2014","journal-title":"Brain"},{"key":"bib35-20250621","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp-2016-313918","article-title":"Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study","volume":"88","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"bib36-20250621","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/archneur.60.12.1745","article-title":"Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study","volume":"60","year":"2003","journal-title":"Arch Neurol"},{"key":"bib37-20250621","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1523\/JNEUROSCI.3874-05.2006","article-title":"A resilient, low-frequency, small-world human brain functional network with highly connected association cortical hubs","volume":"26","year":"2006","journal-title":"J Neurosci"},{"key":"bib38-20250621","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/WNL.54.10.1916","article-title":"Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease","volume":"54","year":"2000","journal-title":"Neurology"},{"key":"bib39-20250621","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/brain\/awr277","article-title":"Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease","volume":"135","year":"2012","journal-title":"Brain"},{"key":"bib40-20250621","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.parkreldis.2017.02.017","article-title":"Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson's disease","volume":"38","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"bib41-20250621","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1017\/S0140525X11000446","article-title":"The brain basis of emotion: a meta-analytic review","volume":"35","year":"2012","journal-title":"Behav Brain Sci"},{"key":"bib42-20250621","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1038\/s41380-022-01772-8","article-title":"Depressive symptoms in cognitively unimpaired older adults are associated with lower structural and functional integrity in a frontolimbic network","volume":"27","year":"2022","journal-title":"Mol Psychiatry"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T15:06:05Z","timestamp":1750518365000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005211","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,8]]}}}